Abstract
The root bark of Aralia elata is the source of araloside A, which has attracted interest because to its possible therapeutic benefits on human kidney cancer cells. This study examines our current knowledge of the mechanisms of action of araloside A and how it affects many facets of the physiology of kidney cancer cells. It is detailed how the substance can cause apoptosis, stop cell growth, and obstruct signaling pathways that are essential for the development of cancer. Furthermore, new experimental results are used to assess its safety and efficacy profiles. To fully utilize Araloside A's therapeutic potential in the treatment of kidney cancer, future research approaches are suggested.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Public Health and Awareness
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
